Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder

Journal of Clinical Psychiatry

Volumn 65, Issue 3, 2004, Pages 379-385

  Simpson, Elizabeth B ^a   Yen, Shirley ^b   Costello, Ellen ^b,c   Rosen, Karen ^b   Begin, Ann ^f   Pistorello, Jacqueline ^d   Pearlstein, Teri ^b,c,e  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c BUTLER HOSPITAL   (United States)

^d UNIVERSITY OF NEVADA   (United States)

^e WOMEN AND INFANTS HOSPITAL   (United States)

^f Massachusetts Mental Health Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR THERAPY; BORDERLINE STATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BEHAVIOR THERAPY; BORDERLINE PERSONALITY DISORDER; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS;

EID: 2342485016     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0314     Document Type: Article

References (28)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Shea MT, Widiger TA, Klein MH. Comorbidity of personality disorders and depression: implications for treatment. J Consult Clin Psychol 1992;60:857-868
3. Perry JC. Longitudinal studies of personality disorders. J Personal Disord Suppl 1993;1:63-85 (Pubitemid 23129884)
4. Soloff PH. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bull Menninger Clin 1998;62:195-214 (Pubitemid 28225365)
5. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Borderline Personality Disorder. Am J Psychiatry 2001;158(suppl 10):1-52
6. Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:885-893 (Pubitemid 19238698)
7. Cornelius JR, Soloff PH, Perel JM, et al. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 1990;26:151-154 (Pubitemid 20322264)
8. Coccaro EF, Astill JL, Herbert JL, et al. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol 1990;10:373-375 (Pubitemid 20378683)
9. Markovitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064-1067
10. Joyce PR, Mulder RT, Luty SE, et al. Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome. Compr Psychiatry 2003;44:35-43 (Pubitemid 36056772)
11. Markovitz PJ. Pharmacotherapy of impulsivity, aggression, and related disorders. In: Hollander E, Stein D, eds. Impulsivity and Aggression. Surrey, United Kingdom: Wiley; 1995
12. Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-141 (Pubitemid 24143118)
13. Markovitz PJ, Wagner SL. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull 1995;31:773-777 (Pubitemid 26091746)
14. Salzman C, Wolfson AN, Schatzberg A, et al. Effects of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-29
15. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: Guilford Press; 1993
16. Linehan MM, Heard H, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993;50:971-974 (Pubitemid 23361477)
17. Linehan MM, Armstrong HE, Suarez A, et al. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-1064
18. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II, Version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute; 1996
19. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). New York, NY: Biometric Research, New York State Psychiatric Institute; 1996
20. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
21. Spielberger C, Gorsuch A, Lushene R. The State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970
22. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al. Development of neuropharmacologically based behavioral assessment of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991;3:44-51
23. Bernstein-Carlson EB, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986;174:727-735 (Pubitemid 17210598)
24. Spielberger CD. State-Trait Anger Expression Inventory: Professional Manual. Odessa, Fla: Psychological Assessment Resources; 1991
25. Stone MH. Clinical guidelines for psychotherapy for patients with borderline personality disorder. Psychiatr Clin North Am 2000;23:193-210 (Pubitemid 30140479)
26. Deltito J, Martin L, Riefkohl J, et al. Do patients with borderline personality disorder belong to the bipolar spectrum? J Affect Disord 2001;67:221-228
27. Akiskal HS. The prevalent clinical spectrum of bipolar disorder: beyond DSM-IV. J Clin Psychopharmacol 1996;16(2 suppl 1):4-14 (Pubitemid 26120571)
28. McGlashan TH, Grilo CM, Skodol AE, et al. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand 2000;102:256-264 (Pubitemid 30749295)